As of 2025-07-05, the Relative Valuation of Turning Point Therapeutics Inc (TPTX) is (94.42) USD. This relative valuation is based on P/E multiples. With the latest stock price at 76.01 USD, the upside of Turning Point Therapeutics Inc based on Relative Valuation is -224.2%.
The range of the Relative Valuation is (92.77) - (131.09) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 19.0x | 13.7x |
| Forward P/E multiples | 12.9x - 21.3x | 13.7x |
| Fair Price | (92.77) - (131.09) | (94.42) |
| Upside | -222.0% - -272.5% | -224.2% |
| Date | P/E |